Trial 6G-22-2


Feasibility Study of Resection and Gammatile® Followed By Concomitant External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant TMZ in Newly Diagnosed Glioblastoma (GBM)

Type: Treatment
Phase: Not Applicable
Status: Open to Accrual
Treatments: Chemotherapy: Systemic, Radiation: External, Radiation: Other, Surgery
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Eric Chang, M.D.
Other Trial Staff:  Aida Lozada, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.